BILLERICA, Mass., Feb. 9, 2018 /PRNewswire/ -- Bruker
Corporation (NASDAQ: BRKR) announced today it will present at the
LEERINK Partners 7th Annual Global Healthcare Conference.
Frank Laukien, President and CEO,
will participate in a "fireside chat" Q&A session on behalf of
the company on Wednesday, February 14th,
2018 at 9:30 AM Eastern
Time.
A live audio webcast of the presentation will be available on
the Investor section of the Company's website at
http://ir.bruker.com. A replay of the presentation will be posted
on the Bruker Corporation website after the event and will be
available for 30 days following the presentation.
About Bruker Corporation
For more than 55 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker's high-performance scientific
instruments and high-value analytical and diagnostic solutions
enable scientists to explore life and materials at molecular,
cellular and microscopic levels. In close cooperation with our
customers, Bruker is enabling innovation, improved productivity and
customer success in life science molecular research, in applied and
pharma applications, in microscopy and nanoanalysis, and in
industrial applications, as well as in cell biology, preclinical
imaging, clinical phenomics and proteomics research, microbiology
and molecular pathology research. For more information, please
visit: www.bruker.com.
Contact:
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com
View original
content:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-leerink-partners-7th-annual-global-healthcare-conference-300596297.html
SOURCE Bruker Corporation